All In Biotech

Free tool

FAERS Monitor: Chorionic Gonadotropin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 017067 or its brand name (Chorionic Gonadotropin, Gonadotropin, Chorionic). Reports on generic versions are filed under their own applications.

Reports

561

Serious

417

74% of reports

Hospitalization

254

Death reported

26

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • ovarian hyperstimulation syndrome130
  • drug ineffective38
  • drug exposure during pregnancy37
  • off label use33
  • ascites31
  • ectopic pregnancy31
  • dyspnoea27
  • nausea27
  • headache26
  • abdominal distension25
  • pain24
  • pleural effusion24
  • abortion spontaneous23
  • abdominal pain21
  • caesarean section19

Reports by year received

View as table
YearReports
20049
200527
200627
200745
200818
200929
201026
201153
201278
201314
201415
20155
201627
201716
201820
201920
202024
202120
202227
202317
202416
202510
202618

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,598 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
ovarian hyperstimulation syndromeSignal1302214.61894.0269,552
ectopic pregnancySignal31381.8270.711,283
caesarean sectionSignal1961.339.41,066
drug exposure during pregnancySignal3740.829.91,399
ascitesSignal3139.628.11,128
abortion spontaneousSignal2321.514.4431
pleural effusionSignal2414.810.0296
abdominal distensionSignal259.06.1170
abdominal painSignal213.42.233
dyspnoea271.81.29
headache261.61.15
pain241.51.03
off label use331.41.04
nausea271.30.91
drug ineffective381.10.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.